Accès à distance ? S'identifier sur le proxy UCLouvain
Is there a place for bone turnover markers in the assessment of osteoporosis and its treatment?
Primary tabs
Document type | Article de périodique (Journal article) – Journal Article, Review |
---|---|
Publication date | 2011 |
Language | Anglais |
Journal information | "Rheumatic Diseases Clinics of North America" - Vol. 37, no. 3, p. 365-386 (2011) |
Peer reviewed | yes |
Publisher | W.B.Saunders Co. ((United States) Maryland Heights) |
issn | 0889-857X |
e-issn | 1558-3163 |
Publication status | Publié |
Affiliations |
UCL
- (SLuc) Service de rhumatologie UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales UCL - (MGD) Service de rhumatologie UCL - (SLuc) Département de biologie clinique et d'anatomie pathologique |
MESH Subject | Osteoporosis, Postmenopausal - diagnosis - drug therapy - metabolism ; Middle Aged ; Humans ; Female ; Drug Monitoring - methods ; Bone and Bones - drug effects - metabolism ; Bone Remodeling - drug effects - physiology ; Bone Density Conservation Agents - therapeutic use ; Biological Markers - metabolism |
Links |
Bibliographic reference | Devogelaer, Jean-Pierre ; Boutsen, Yves ; Gruson, Damien ; Manicourt, Daniel. Is there a place for bone turnover markers in the assessment of osteoporosis and its treatment?. In: Rheumatic Diseases Clinics of North America, Vol. 37, no. 3, p. 365-386 (2011) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/106223 |